$80,000 of ORACLE CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY2026 Military Construction/VA Appropriations Bill - Electronic Health Record Veterans electronic health record DOD Healthcare, Electronic Health Record"
You can find more data on corporate lobbying on Quiver Quantitative.
ORCL Congressional Stock Trading
Members of Congress have traded $ORCL stock 13 times in the past 6 months. Of those trades, 6 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $200,000 on 09/23, 09/18, 09/17 and 0 sales.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 09/15, 09/12.
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/16 and 1 sale worth up to $15,000 on 09/12.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/08 and 1 sale worth up to $50,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ORCL Insider Trading Activity
ORCL insiders have traded $ORCL stock on the open market 47 times in the past 6 months. Of those trades, 1 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:
- SAFRA CATZ (Chief Executive Officer) has made 0 purchases and 31 sales selling 8,694,918 shares for an estimated $1,825,887,891.
- JEFFREY HENLEY (Vice Chairman) has made 0 purchases and 2 sales selling 400,000 shares for an estimated $76,169,016.
- MICHAEL D. SICILIA (President, Industries) has made 0 purchases and 3 sales selling 66,048 shares for an estimated $20,029,695.
- CLAYTON M. MAGOUYRK (President, OCI) has made 0 purchases and 2 sales selling 36,241 shares for an estimated $9,522,348.
- STUART LEVEY (EVP, Chief Legal Officer) sold 19,758 shares for an estimated $5,927,400
- WILLIAM G PARRETT sold 11,500 shares for an estimated $3,519,000
- LEON E PANETTA sold 17,500 shares for an estimated $2,646,651
- MARIA SMITH (EVP, Chief Accounting Officer) sold 10,000 shares for an estimated $2,329,897
- NAOMI O SELIGMAN has made 0 purchases and 3 sales selling 8,391 shares for an estimated $1,841,175.
- GEORGE H CONRADES sold 8,169 shares for an estimated $1,743,999
- RONA ALISON FAIRHEAD purchased 480 shares for an estimated $112,257
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ORCL Hedge Fund Activity
We have seen 1,806 institutional investors add shares of ORCL stock to their portfolio, and 1,430 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FISHER ASSET MANAGEMENT, LLC removed 8,714,141 shares (-49.5%) from their portfolio in Q2 2025, for an estimated $1,905,172,646
- FMR LLC removed 7,143,518 shares (-22.3%) from their portfolio in Q2 2025, for an estimated $1,561,787,340
- NORGES BANK added 6,255,302 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $1,367,596,676
- FRANKLIN RESOURCES INC removed 6,076,996 shares (-38.1%) from their portfolio in Q2 2025, for an estimated $1,328,613,635
- VICTORY CAPITAL MANAGEMENT INC added 5,925,776 shares (+683.5%) to their portfolio in Q2 2025, for an estimated $1,295,552,406
- AMUNDI removed 5,486,321 shares (-43.1%) from their portfolio in Q2 2025, for an estimated $1,199,474,360
- CAPITAL RESEARCH GLOBAL INVESTORS added 4,033,717 shares (+21.2%) to their portfolio in Q2 2025, for an estimated $881,891,547
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ORCL Analyst Ratings
Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 22 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 10/10/2025
- Baird issued a "Outperform" rating on 10/09/2025
- Bernstein issued a "Outperform" rating on 09/26/2025
- Rothschild & Co issued a "Sell" rating on 09/25/2025
- JMP Securities issued a "Market Outperform" rating on 09/24/2025
- Barclays issued a "Overweight" rating on 09/11/2025
- UBS issued a "Buy" rating on 09/10/2025
To track analyst ratings and price targets for ORCL, check out Quiver Quantitative's $ORCL forecast page.
ORCL Price Targets
Multiple analysts have issued price targets for $ORCL recently. We have seen 29 analysts offer price targets for $ORCL in the last 6 months, with a median target of $350.0.
Here are some recent targets:
- Kirk Materne from Evercore ISI Group set a target price of $350.0 on 10/10/2025
- Rob Oliver from Baird set a target price of $365.0 on 10/09/2025
- Mark L. Moerdler from Bernstein set a target price of $364.0 on 09/26/2025
- Alex Haissl from Rothschild & Co set a target price of $175.0 on 09/25/2025
- Patrick Walravens from JMP Securities set a target price of $342.0 on 09/24/2025
- Keith Weiss from Morgan Stanley set a target price of $320.0 on 09/23/2025
- Nay Soe Naing from Berenberg set a target price of $306.0 on 09/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
